; (B) facilitating the use and dissemination of such standards among State and local governments by— (i) providing technical assistance to State, local, and Tribal governments seeking to adopt or implement such standards; and (ii) coordinating seminars and training sessions for State, local, and Tribal governments seeking to adopt or implement such standards. (c) Private sector (1) In general The Director or the head of a National Drug Control Program (as designated by the Director) shall coordinate with the private sector to promote private research and development of medications to treat or prevent addiction, including research and development for non-addictive pain management medication, abuse deterrent formulations, medication-assisted treatment, and other addiction research determined to be necessary by the Director by— (A) encouraging the sharing of information regarding evidence-based treatment addiction findings and related data between agencies and the private sector, as appropriate; (B) encouraging collaboration between appropriate agencies and the private sector; and (C) providing private sector entities with relevant statistical data and information to enhance research as permissible. (2) Working group The Director may establish a working group of National Drug Control Program Agencies, State, local, and Tribal governments, and the private sector stakeholders to discuss and disseminate best practices, research and development, and other related issues, as appropriate. (d) Model Acts Program (1) In general The Director shall provide for or shall enter into an agreement with a nonprofit organization to— (A) advise States on establishing laws and policies to address illicit drug use issues